tradingkey.logo
tradingkey.logo
Search

Humacyte Inc

HUMA
Add to Watchlist
0.557USD
-0.009-1.59%
Market hours 09/24, 15:54(ET)
150.19MMarket Cap
LossP/E TTM

HUMA Financials

See Humacyte Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
150.19M
Dividend TTM
0.00
P/E TTM
-0.86
EPS TTM
-0.64
Revenue
2.04M
Net Profit
-148.70M
ROE
-409.47%
ROA
-71.47%

Humacyte Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.16/-0.10
Revenue / Forecast
406.00K/1.12M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
35.13%-0.16
-129.92%-0.09
19.57%-0.13
66.31%-0.11
49.05%-0.24
201.01%0.30
31.98%-0.16
-30.65%-0.33
-116.43%-0.48
17.70%-0.29
-571.96%-0.24
---0.25
---0.22
---0.36
---0.04
----
----
----
----
----
Revenue
34.88%406.00K
-4.26%495.00K
--467.00K
--753.00K
--301.00K
--517.00K
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-87.14%31.00K
88.55%1.30M
50.32%233.00K
42.74%177.00K
-73.63%241.00K
Net Profit
2.27%-36.80M
-145.02%-17.62M
-18.45%-24.80M
55.33%-17.51M
33.54%-37.66M
222.71%39.14M
16.59%-20.94M
-50.81%-39.20M
-149.55%-56.66M
13.72%-31.90M
-574.89%-25.11M
-2.82%-26.00M
-161.59%-22.71M
-86.41%-36.97M
-108.74%-3.72M
19.90%-25.28M
314.37%36.87M
2.31%-19.83M
362.68%42.59M
-77.72%-31.56M
Net Margin
27.55%-9064.53%
-147.02%-3559.39%
---5311.35%
---2325.37%
---12510.96%
--7570.41%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
-795.04%-203.20%
-535.56%-311.72%
---1844.75%
--65.47%
--29.24%
--71.57%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
285.87%47.93%
452.42%59.61%
364.60%55.73%
268.52%55.26%
-3.88%12.42%
-5.89%10.79%
-18.42%11.99%
15.23%15.00%
8.52%12.92%
-57.91%11.47%
-39.94%14.70%
--13.01%
--11.91%
--27.24%
--24.48%
----
----
----
----
----
Revenue
34.88%406.00K
-4.26%495.00K
--467.00K
--753.00K
--301.00K
--517.00K
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-87.14%31.00K
88.55%1.30M
50.32%233.00K
42.74%177.00K
-73.63%241.00K
Operating profit
9.19%-27.00M
-24.81%-28.93M
-9.78%-30.84M
19.33%-24.39M
-0.77%-29.73M
12.77%-23.18M
-7.28%-28.09M
-22.79%-30.23M
-10.36%-29.50M
-18.06%-26.58M
-25.94%-26.18M
-4.80%-24.62M
-44.25%-26.73M
-3.44%-22.51M
3.87%-20.79M
-14.36%-23.49M
3.83%-18.53M
-10.09%-21.76M
-38.00%-21.63M
-19.35%-20.54M
Net Profit
2.27%-36.80M
-145.02%-17.62M
-18.45%-24.80M
55.33%-17.51M
33.54%-37.66M
222.71%39.14M
16.59%-20.94M
-50.81%-39.20M
-149.55%-56.66M
13.72%-31.90M
-574.89%-25.11M
-2.82%-26.00M
-161.59%-22.71M
-86.41%-36.97M
-108.74%-3.72M
19.90%-25.28M
314.37%36.87M
2.31%-19.83M
362.68%42.59M
-77.72%-31.56M
Current assets
79.37%92.79M
-13.71%63.60M
41.66%67.80M
79.75%41.35M
-46.18%51.73M
-37.50%73.70M
-42.53%47.86M
-77.63%23.00M
-20.28%96.11M
-11.90%117.93M
-46.00%83.28M
-41.10%102.85M
-37.54%120.56M
-36.04%133.85M
-32.76%154.21M
-28.49%174.61M
519.88%193.03M
--209.29M
--229.34M
--244.18M
Total current liabilities
-29.11%14.95M
-19.18%16.19M
-7.93%18.37M
22.15%25.58M
18.74%21.09M
42.18%20.03M
8.19%19.95M
38.35%20.94M
55.93%17.76M
-40.31%14.09M
-5.81%18.44M
-15.46%15.14M
2.98%11.39M
119.28%23.60M
77.19%19.58M
-15.72%17.91M
-30.68%11.06M
--10.76M
--11.05M
--21.25M
Total assets
-0.51%138.09M
-31.99%110.56M
-15.60%116.37M
-20.26%91.51M
0.37%138.79M
0.67%162.55M
7.53%137.87M
-23.18%114.76M
-17.74%138.28M
-11.76%161.47M
-37.24%128.22M
-33.96%149.38M
-31.77%168.11M
-30.81%182.98M
-28.70%204.30M
-25.43%226.22M
157.83%246.37M
--264.47M
--286.53M
--303.36M
Total liabilities
-20.72%106.83M
-21.80%98.93M
-40.56%113.26M
-46.07%96.26M
-19.11%134.74M
-6.51%126.51M
66.15%190.54M
58.81%178.49M
55.69%166.57M
33.86%135.31M
31.25%114.68M
4.51%112.39M
2.77%106.99M
-37.05%101.09M
-46.84%87.37M
-52.73%107.55M
91.63%104.11M
--160.58M
--164.36M
--227.50M
Total equity
671.50%31.26M
-67.75%11.62M
105.90%3.11M
92.54%-4.75M
114.32%4.05M
37.82%36.04M
-488.82%-52.67M
-272.25%-63.72M
-146.28%-28.29M
-68.06%26.15M
-88.42%13.55M
-68.83%36.99M
-57.04%61.12M
-21.18%81.89M
-4.29%116.93M
56.43%118.67M
245.07%142.26M
--103.89M
--122.17M
--75.86M
Net operating income
16.48%-22.06M
12.23%-25.10M
1.70%-26.12M
-4.35%-23.90M
-24.06%-26.41M
-4.59%-28.60M
-39.48%-26.58M
-76.11%-22.91M
5.80%-21.29M
-46.70%-27.35M
-0.50%-19.05M
22.60%-13.01M
-36.42%-22.60M
0.83%-18.64M
11.60%-18.96M
44.94%-16.80M
-12.87%-16.57M
-29.25%-18.80M
-41.15%-21.45M
-138.60%-30.52M
Net investment
81.69%-104.00K
23.25%-175.00K
38.10%-39.00K
94.75%-49.00K
-208.70%-568.00K
41.69%-228.00K
58.00%-63.00K
-89.45%-934.00K
-111.34%-184.00K
66.06%-391.00K
-102.88%-150.00K
-133.65%-493.00K
1310.45%1.62M
-5136.36%-1.15M
164.79%5.21M
-154.22%-211.00K
-112.70%-134.00K
24.14%-22.00K
-61784.62%-8.04M
-418.75%-83.00K
Net financing
2371.33%53.53M
-50.10%23.32M
12.09%57.17M
-5352.18%-44.59M
563.81%2.17M
-25.57%46.74M
15325.67%51.01M
211.13%849.00K
-107.76%-467.00K
15453.30%62.80M
-58.02%-335.00K
-164.36%-764.00K
1342.77%6.01M
11.28%-409.00K
-103.24%-212.00K
-100.12%-289.00K
47.16%-484.00K
-102.39%-461.00K
2101.83%6.55M
65001.34%242.08M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its total revenue reached 2.04M, with a year-on-year change of 2.04M.

What are the current assets of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its current assets were 67.80M, with a year-on-year change of 41.66.

What are the total assets of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its total assets of Humacyte Inc were 116.37M, with a year-on-year change of -15.60.

What are the total liabilities of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its total liabilities of Humacyte Inc were 113.26M, with a year-on-year change of -40.56.

What is the total equity of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its total equity of Humacyte Inc was 3.11M, with a year-on-year change of 105.90.

What is the net operating income of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its net operating income of Humacyte Inc was -108.14M, with a year-on-year change of 5.47.

What is the net investment of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its net investment of Humacyte Inc was -884.00K, with a year-on-year change of 43.77.

What is the net financing of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its net financing of Humacyte Inc was 61.49M, with a year-on-year change of -46.15.

What is the Earnings Per Share (EPS) of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.26, with a year-on-year change of 79.43.

What is the net income of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its net income was -40.83M, with a year-on-year change of 72.54.

What is the debt-to-asset ratio of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its debt-to-asset ratio was 55.73, with a year-on-year change of -3.83.

What is the Return on Assets (ROA) of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its Return on Assets (ROA) was -32.12, with a year-on-year change of 71.26.

What is the operating profit of Humacyte Inc?

According to Humacyte Inc's FY2025 earnings report, its operating profit was -108.14M, with a year-on-year change of 5.47.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.